[1] HARBECK N, GNANT M. Breast cancer[J].Lancet,2017,389(10074):1134-1150. [2] DENKERT C, LIEDTKE C, TUTT A, et al. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies[J].Lancet,2017, 389(10087):2430-2442. [3] 何江洋,李奉喜,黄垂国,等.胰腺癌特异性差异表达lncRNA相关的ceRNA调控网络的构建[J].郑州大学学报:医学版,2018,53(4):457-462. [4] FABIAN M R, SONENBERG N, FILIPOWICZ W. Regulation of mRNA translation and stability by microRNAs[J]. Annu Rev Biochem, 2010, 79:351-379. [5] LI X D, WU X F. MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7[J]. Onco Targets Ther, 2018, 11:8445-8454. [6] GHORBANMEHR N, GHARBI S, KORSCHING E, et al. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer[J]. Prostate, 2019, 79(1):88-95. [7] 何建林, 梅振宇, 盛勇,等. 三阴性乳腺癌新辅助治疗研究进展[J]. 中国肿瘤外科杂志, 2018, 10(5):330-332. [8] HE Q, XUE S Y, TAN Y Q, et al. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer[J]. Cancer Lett, 2019, 448:94-104. [9] FAN C, LIU N. Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple-negative breast cancer:an in silico study[J]. Oncol Rep, 2019, 41(6):3313-3324. [10] BHARDWAJ A, SINGH H, RAJAPAKSHE K, et al. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer[J]. Oncotarget, 2017, 8(12):19645-19660. [11] MALLA R R, KUMARI S, GAVARA M M, et al. A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer[J]. Biophys Rev, 2019, 11(2):227-234. [12] PIASECKA D, BRAUN M, KORDEK R, et al. MicroRNAs in regulation of triple-negative breast cancer progression[J]. J Cancer Res Clin Oncol, 2018, 144(8):1401-1411. [13] PEREZ-AÑORVE I X, GONZALEZ-DE LA ROSA C H, SOTO-REYES E, et al. New insights into radioresistance in breast cancer identify a dual function of miR-122 as a tumor suppressor and oncomiR[J]. Mol Oncol, 2019, 13(5):1249-1267. [14] LI X H, CHEN D, LI M F, et al. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells[J]. Chem Biol Interact, 2018, 288:76-82. [15] DAI J W, LIN Y Y, DUAN Y F, et al. Andrographolide inhibits angiogenesis by inhibiting the Mir-21-5p/TIMP3 signaling pathway[J]. Int J Biol Sci, 2017, 13(5):660-668. [16] PARK S K, PARK Y S, AHN J Y, et al. MiR 21-5p as a predictor of recurrence in young gastric cancer patients[J]. J Gastroenterol Hepatol,2016,31(8):1429-1435. [17] KOWALCZYK A E, KRAZINSKI B E, GODLEWSKI J, et al. SATB1 is down-regulated in clear cell renal cell carcinoma and correlates with miR-21-5p overexpression and poor prognosis[J]. Cancer Genomics Proteomics, 2016,13(3):209-217. [18] YU W H, ZHU K X, WANG Y L, et al. Overexpression of miR-21-5p promotes proliferation and invasion of colon adenocarcinoma cells through targeting CHL1[J]. Mol Med, 2018,24(1):36. |